Early management of COPD: where are we now and where do we go from here? A Delphi consensus project
Open Access
- 1 February 2019
- journal article
- research article
- Published by Informa UK Limited in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 14, 353-360
- https://doi.org/10.2147/copd.s176662
Abstract
Purpose: There is a lack of consensus on the most appropriate early diagnostic strategy, criteria for early access to treatment and follow-up approach for patients with COPD. Materials and methods: A Delphi consensus project investigated the early management of COPD. We formulated two questionnaires for completion by pneumologists in Italy. Results: A total of 207 specialists completed questionnaire 1 and 184 of them questionnaire 2, between November 2016 and October 2017. Early diagnosis of COPD was considered uncommon for 93.2% of the expert panel. Regardless of the definition of “early diagnosis” – a diagnosis made before the clinical manifestation of the disease for most responders (60.4%) – experts were confident of the positive effects of early disease management, which they consider is effective in modifying the natural history of the disease. Lack of awareness of the disease was considered the first limiting factor to early COPD management for 78% of respondents. The most effective steps to reduce functional decline were considered to be smoking cessation, followed by long-acting β2-agonist (LABA)/long-acting muscarinic antagonist (LAMA), LAMA, LABA, and finally inhaled corticosteroid/LABA (PConclusion: Early management of COPD is uncommon, and although data on the effects of early disease management on long-term outcomes are limited, Italian experts are confident of the clinical efficacy of this approach.Keywords
This publication has 35 references indexed in Scilit:
- Project PriMo: Sharing principles and practices of bronchodilator therapy monitoring in COPD: A consensus initiative for optimizing therapeutic appropriateness among Italian specialistsPulmonary Pharmacology & Therapeutics, 2013
- New bronchodilatorsCurrent Opinion in Pharmacology, 2012
- Factors Associated with Medication Adherence in Patients with Chronic Obstructive Pulmonary DiseaseRespiration, 2011
- The scientific rationale for combining long-acting β2-agonists and muscarinic antagonists in COPDPulmonary Pharmacology & Therapeutics, 2010
- Impact of exacerbations on COPDEuropean Respiratory Review, 2010
- Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax, 2002
- Association between health-related quality of life and consultation for respiratory symptoms: results from the DIMCA programmeEuropean Respiratory Journal, 1998
- Qualitative Research: Consensus methods for medical and health services researchBMJ, 1995
- Consensus methods: characteristics and guidelines for use.American Journal of Public Health, 1984
- The natural history of chronic airflow obstruction.BMJ, 1977